scholarly journals Chronic heart failure: actual aspects of treatment in real clinical practice

2019 ◽  
pp. 50-58
Author(s):  
D. I. Trukhan ◽  
E. L. Davydov
Keyword(s):  
Heart Failure ◽  
Clinical Practice ◽  
Drug Therapy ◽  
Chronic Heart Failure ◽  
Sinus Node ◽  
Public Health Problem ◽  
Point Of View ◽  
Primary Health ◽  
Long Time ◽  
Real Clinical Practice

An urgent public health problem is the optimization of drug therapy in patients with chronic heart failure.A large number of works devoted to the treatment of chronic heart failure form the point of view that about the treatment of chronic heart failure «all is well known for a long time.» However, in real clinical practice, especially at the stage of primary health care, for various reasons, possible pitfalls, reefs and shallows are not taken into account, the underestimation of which can introduce certain difficulties and cause the treatment of patients with chronic heart failure to be ineffective.The review article examined a number of important aspects of the treatment of chronic heart failure, which, for various reasons, are underestimated in the supervision of patients. First of all, this refers to antagonists of mineralocorticoid receptors, in particular to spironolactone, and an inhibitor of If - channels of the sinus node ivabradine.The results of foreign and Russian studies, modern recommendations for the supervision of patients with chronic heart failure, indicate that the presence of spironolactone and ivabradine in the arsenal of a practical doctor allows optimizing drug therapy in patients with chronic heart failure and increasing its effectiveness.

scholarly journals CHRONIC HEART FAILURE: CLINICAL GUIDELINES AND REAL CLINICAL PRACTICE

2016 ◽  
Vol 12 (6) ◽  
pp. 631-637 ◽  
Author(s):  
E. K. Shavarova ◽  
L. A. Babaeva ◽  
S. S. Padaryan ◽  
N. N. Soseliya ◽  
O. I. Lukina ◽  
...  
Keyword(s):  
Heart Failure ◽  
Clinical Practice ◽  
Chronic Heart Failure ◽  
Clinical Guidelines ◽  
Real Clinical Practice

scholarly journals The use of beta-blockers in patients with chronic obstructive pulmonary disease and chronic heart failure in real clinical practice

2021 ◽  
Vol 2 (1) ◽  
pp. 70-75
Author(s):  
N. A. Karoli ◽  
A. V. Borodkin ◽  
A. P. Rebrov
Keyword(s):  
Heart Failure ◽  
Chronic Obstructive Pulmonary Disease ◽  
Clinical Practice ◽  
Chronic Heart Failure ◽  
Pulmonary Disease ◽  
Beta Blockers ◽  
Dose Titration ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Real Clinical Practice

Objective: to reveal the features of the use of beta-blockers (BB) in patients with chronic obstructive pulmonary disease (COPD) and chronic heart failure (CHF) in real clinical practice.Materials and methods: the study included 90 patients with COPD and CHF, and 41 patients with CHF of ischemic genesis without COPD.Results: patients with COPD and CHF were significantly less likely to receive beta-blockers (BB) compared with patients with CHF. Of the BB patients with COPD and CHF were primarily prescribed bisoprolol, its average dose was 4.45 ± 1.74 mg per day. Patients with COPD and CHF of ischemic genesis of BB were prescribed significantly more often, and diuretics were significantly less likely than patients with COPD and CHF without myocardial infarction. Patients with COPD and CHF with ejection fraction of the left ventricle (LVEF) more than 40% were less likely to take BB than patients with COPD and CHF with reduced EF (less than 40%), and also less frequently, than patients with CHF without COPD with LVEF more than 40%.Conclusion: BB, as first-line drugs in the treatment of CHF, was prescribed on an outpatient basis only to half of patients with COPD and CHF, which does not comply with current guidelines for the management of patients with comorbid conditions. In the vast majority of cases, highly selective BB were prescribed. It should be noted low doses of BB, the absence of dose titration, which does not correspond to modern recommendations for the treatment of chronic heart failure.

scholarly journals Chronic Heart Failure Clinical Practice Guidelines’ Class 1-A Pharmacologic Recommendations: Start-to-End Synergistic Drug Therapy?

2016 ◽  
Vol 24 (1) ◽  
Author(s):  
Ramon F. Abarquez ◽  
Paul Ferdinand M. Reganit ◽  
Carmen N. Chungunco ◽  
Jean Alcover ◽  
Felix Eduardo R. Punzalan ◽  
...  
Keyword(s):  
Heart Failure ◽  
Clinical Practice ◽  
Drug Therapy ◽  
Chronic Heart Failure ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Class 1

scholarly journals CHRONIC HEART FAILURE IN REAL CLINICAL PRACTICE

2019 ◽  
Vol 12 (5) ◽  
pp. 45-49
Author(s):  
ALLA A. PODOLSKAYA ◽  
◽  
LYUBOV YU. PALMOVA ◽  
ZULFIYA A. SHAIKHUTDINOVA ◽  
◽  
...  
Keyword(s):  
Heart Failure ◽  
Clinical Practice ◽  
Chronic Heart Failure ◽  
Real Clinical Practice

scholarly journals Management of patients with chronic heart failure and diabetes mellitus from the standpoint of modern recommendations and in real clinical practice

2020 ◽  
Vol 22 (5) ◽  
pp. 50-56
Author(s):  
Elena V. Reznik ◽  
◽  
Vladimir A. Lazarev ◽  
Marina R. Kalova ◽  
Marina R. Kalova ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Heart Failure ◽  
Clinical Practice ◽  
Chronic Heart Failure ◽  
Real Clinical Practice

scholarly journals Progress in drug treatment of older patients with chronic heart failure

2020 ◽  
Vol 2 (4) ◽  
pp. 176-179
Author(s):  
Siting Zhang ◽  
◽  
Feng Liu
Keyword(s):  
Heart Failure ◽  
Drug Therapy ◽  
Chronic Heart Failure ◽  
Drug Treatment ◽  
Older Patients ◽  
Clinical Symptoms ◽  
Public Health Problem ◽  
The Elderly ◽  
High Morbidity ◽  
Keywords Aging

Chronic heart failure(CHF) is a serious public health problem in the world, which occurs mostly in the elderly,with extremely high morbidity and mortality. The physiological changes in the cardiovascular system caused by aging are an independent risk factor for CHF. For this reason, effective drug treatment is often used to improve the clinical symptoms and quality of life of older CHF patients, and ultimately achieve the goal of reducing hospitalization rate and cardiovascular mortality. This article describes recent progress of drug therapy for older patients in chronic heart failure. Keywords: Aging, older patients, chronic heart failure, drug therapy

scholarly journals SUPPORTING DEVICES IN THE TREATMENT OF CHRONIC HEART FAILURE IN ELDERLY AND OLD PATIENTS

2020 ◽  
Vol 2 (3) ◽  
pp. 40-57
Author(s):  
Gennadiy Hubulava ◽  
Kirill L. Kozlov ◽  
Andrey N. Bogomolov ◽  
Aleksey Volkov ◽  
Viktor N. Fedorets ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Heart Failure ◽  
Clinical Practice ◽  
Chronic Heart Failure ◽  
Severe Heart Failure ◽  
Circulatory Support ◽  
Old Patients ◽  
Western Countries ◽  
Surgical Methods

Chronic heart failure (CHF) is a widespread disease associated with high rates of disability and mortality, as well as a decrease in the quality of life. Moreover, the vast majority of patients are elderly and senile. Modern surgical methods of treating heart failure are able to increase the duration and quality of life of such patients, however, the need far exceeds the volume of this care, and some highly effective methods common in Western countries are still not used in Russian clinical practice. Elderly age is a risk factor for the development of senile asthenia (frailty) and concomitant pathology. Large abdominal surgery is often contraindicated for patients with signs of senile asthenia, and the method of choice in patients with severe heart failure is the implantation of devices for long-term mechanical circulatory support (LT-MCS). After implantation of LT-MCS, a regression of signs of senile asthenia may be observed. The topic of an integrated approach to non-drug treatment of heart failure in elderly and senile patients in Russia has not been studied enough. In particular, the implantation of LT-MCS is not used in Russian clinical practice, while in many Western countries for many years it has been the main and most effective treatment for severe heart failure. Systematization of the available up-to-date information on this topic could help increase the duration and quality of life of patients with severe heart failure.

scholarly journals Principles of organization of medical care for patients with heart failure in the system of cardiovascular risk management: focus on continuity of care and patient routing. Practical materials

2021 ◽  
Vol 26 (3S) ◽  
pp. 4558 ◽  
Author(s):  
S. V. Villevalde ◽  
A. E. Soloveva ◽  
N. E. Zvartau ◽  
N. G. Avdonina ◽  
A. N. Yakovlev ◽  
...  
Keyword(s):  
Heart Failure ◽  
Risk Management ◽  
Clinical Practice ◽  
Cardiovascular Risk ◽  
Medical Care ◽  
Optimal Model ◽  
Cardiovascular Risk Management ◽  
Patients With Heart Failure ◽  
The Russian Federation ◽  
Real Clinical Practice

The extent of the problem of heart failure determines the priority of the intention of developing and implementing an optimal model of medical care for this group of patients. The article describes the key components of the heart failure medical care (continuity, patient routing, educational activities) and provides examples of documents, protocols, checklists that can be used in real clinical practice by specialists in medical organizations in the regions of the Russian Federation.

Sign in / Sign up

Export Citation Format

Share Document